1. |
Jabs DA. Ocular toxoplasmosis[J]. Int Ophthalmol Clin, 1990, 30(4): 264-270. DOI: 10.1097/00004397-199030040-00009.
|
2. |
Rothova A. Ocular involvement in toxoplasmosis[J]. Br J Ophthalmol, 1993, 77(6): 371-377. DOI: 10.1136/bjo.77.6.371.
|
3. |
Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis[J]. Ophthalmic Res, 2017, 57(1): 1-12. DOI: 10.1159/000449169.
|
4. |
Park YH, Nam HW. Clinical features and treatment of ocular toxoplasmosis[J]. Korean J Parasitol, 2013, 51(4): 393-399. DOI: 10.3347/kjp.2013.51.4.393.
|
5. |
乐杰. TORCH感染[M]//张丹, 王德智, 罗焕. 中国妇产科专家经验文集(2). 沈阳: 辽宁科学技术出版社, 2001: 391-393.Le J. TORCH infection[M]. Zhang D, Wang DZ, Luo H. Collected works of chinese obstetrics and gynecology experts (2). Shenyang: Liaoning Science and Technology Press, 2001: 391-393.
|
6. |
刘棣临. 宫内感染的诊断与防治[M]//张丹, 王德智, 罗焕. 中国妇产科专家经验文集(2).沈阳:辽宁科学技术出版社, 2001: 411-414.Liu DL. Diagnosis and prevention of intrauterine infection [M]//Zhang D, Wang DZ, Luo H. Collected works of chinese obstetrics and gynecology experts (2). Shenyang: Liaoning Science and Technology Press, 2001: 411-414.
|
7. |
Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis[J]. Am J Ophthalmol, 1996, 122(3): 309-324. DOI: 10.1016/S0002-9394(14)70986-9.
|
8. |
Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, et al. Ocular toxoplasmosis: clinical features and prognosis of 154 patients[J]. Ophthalmology, 2002, 109(5): 869-878. DOI: 10.1016/S0161-6420(02)00990-9.
|
9. |
Kim SJ, Scott IU, Brown GC, et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology[J]. Ophthalmology, 2013, 120(2): 371-378. DOI: 10.1016/j.ophtha.2012.07.061.
|
10. |
Harrell M, Carvounis PE. Current treatment of toxoplasma retinochoroiditis: an evidence-based review[J/OL]. J Ophthalmol, 2014, 2014: 273506[2014-08-13]. http://europepmc.org/article/MED/25197557. DOI:10.1155/2014/273506.
|
11. |
Butler NJ, Furtado JM, Winthrop KL, et al. Ocular toxoplasmosis Ⅱ: clinical features, pathology and management[J]. Clin Exp Ophthalmol, 2013, 41(1): 95-108. DOI: 10.1111/j.1442-9071.2012.02838.x.
|
12. |
Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis[J]. Am J Ophthalmol, 2002, 134(1): 102-114. DOI: 10.1016/S0002-9394(02)01526-X.
|
13. |
Maenz M, Schluter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease[J]. Prog Retin Eye Res, 2014, 39: 77-106. DOI: 10.1016/j.preteyeres.2013.12.005.
|